Weston family to buy UK pharmacy chain Boots in $8.9bn deal

News · October 07, 2026, 17:47 UTC · Based on reporting by the Guardian, Yahoo Finance, City AM; the original documents or statements were not available to us at the time of publication.

Canada’s Weston family has agreed to acquire the UK pharmacy and beauty retailer Boots for about $8.9 billion, the companies said on Wednesday, October 7, 2026. Wittington Investments, the family’s holding company, will take operational control of Boots’ UK and Irish retail operations, its opticians chain, the No7 beauty brand, and a franchise arm in Thailand.

Fairfax Financial Holdings Limited, a Toronto-based holding company, is partnering on the transaction. The deal marks the exit of Boots’ long-term backer Stefano Pessina and his latest backer, the financial firm Sycamore Partners, according to The Guardian.

What happened

Wittington Investments said it will buy Boots from its private equity owners, Sycamore Partners, for a total purchase price of approximately US$8.9 billion, inclusive of assumed debt. The Guardian reported the price as $8.9 billion, or £6.74 billion.

Fairfax said in a press release on October 7 that it has agreed to provide up to approximately US$2.3 billion in equity for the purchase price. Following closing, Fairfax is expected to own 50 percent of Boots’ equity, while Wittington will have operational control and Galen Weston will serve as chair of Boots.

The transaction is subject to regulatory approval and customary closing conditions. It is expected to be completed in the first quarter of 2027, according to the companies.

Boots is headquartered in Nottingham and has 1,800 stores across the UK, employing 50,000 people, The Guardian reported. The deal does not include Boots’ businesses in Germany and Mexico, which will be retained by their current owner, according to Fairfax.

Stefano Pessina and his family will keep Boots’ stakes in Mexican drugstore chain Farmacias Benavides and pharma group Alliance Healthcare Deutschland, City AM reported.

Galen Weston, chair of Wittington and likely to become chair of Boots, said Boots is “one of Britain’s most enduring businesses, with a rich heritage, a trusted name, and a vital role in everyday life across the UK and Ireland.”

He added that the family sees “a meaningful opportunity to make a great business even better through stable long-term ownership, further capital investment, and the renewed operating focus required to serve customers with excellence for generations to come.”

Prem Watsa, chairman and chief executive of Fairfax, said the Westons have grown some of Canada’s most successful retail brands, including in pharmacy and beauty, and that Fairfax is confident Wittington will be “an excellent steward of the Boots business.”

Alex Baldock, who joined Boots as chief executive just last month, said the opportunity ahead is “even greater” and that he looks forward to “building a world-class Boots” for colleagues, customers, patients, and communities, according to City AM.

Analysis: Why it matters for investors

The acquisition ends months of speculation over whether Boots could return to the London Stock Exchange. City AM reported that hopes of a blockbuster London IPO had been raised earlier this year when Australian pharmacy giant Sigma Healthcare quit talks over a private sale, leaving just an IPO and the Westons as the company’s two options.

The deal brings Boots back into the orbit of a family with deep retail experience. Wittington is the controlling shareholder of George Weston Limited and, through it, Loblaw Companies Limited and Choice Properties. Loblaw is Canada’s largest grocery retailer and owns Shoppers Drug Mart, the nation’s largest pharmacy, health and beauty business, according to Fairfax.

The Weston family’s Canadian branch is also returning to the UK high street after selling the Selfridges department store chain for £4 billion in 2022, The Guardian noted. A separate UK branch of the family holds a majority stake in Primark through parent company Associated British Foods, which is led by family member George Weston.

Richard Hyman, a veteran retail analyst, described the Weston family as “the most encouraging ownership of Boots for many, many years,” according to The Guardian. He said watching Boots had been “a bit like watching corporate pass the parcel.”

For Fairfax, the deal adds another UK consumer asset. Fairfax owns The Sporting Life Group and Sleep Country, Canada’s largest mattress retailer, which owns Simba Sleep in the UK, The Guardian reported.

Who is affected

The transaction affects Boots’ 50,000 UK employees and its customers across 1,800 stores. It also affects Stefano Pessina, who took Boots private with backing from investment firm KKR in 2007 and has kept a stake under different private equity owners since then.

Pessina said it had been “one of the privileges” of his and his wife Ornella’s life to have been closely associated with Boots over the last 20 years. He said they were “delighted to be passing on a thriving Boots to strong and reliable owners who understand the value of its great heritage.”

Sycamore Partners exits as the seller. The deal also affects Fairfax shareholders, given the company’s commitment of up to $2.3 billion in equity and its expected 50 percent ownership stake.

What is still uncertain

The sources do not say how the purchase price will be split between equity and assumed debt beyond Fairfax’s disclosed equity commitment. The full transaction documents were not available to brokertable.net for review, and details are based on reporting by The Guardian, City AM and Fairfax’s press release.

Regulatory approval has not yet been obtained. The companies said the deal is subject to customary closing conditions, but they did not specify which regulators will review the transaction or whether any store divestitures might be required.

The future strategy for Boots under Wittington’s operational control has not been detailed. While Galen Weston spoke of capital investment and renewed operating focus, the companies did not disclose specific investment amounts, store expansion plans or changes to the Boots brand portfolio.

Conclusion: What to watch next

The key milestone is regulatory approval. The companies expect the transaction to close in the first quarter of 2027, but that timeline depends on clearance from competition and other authorities.

Investors and retail analysts will also watch for any signals from Wittington about operational changes at Boots, including potential investment in stores, digital operations or the No7 beauty brand. Galen Weston’s expected appointment as chair of Boots will put a familiar retail name at the top of one of Britain’s most recognized high street businesses.

For the London market, the deal removes a potential IPO candidate. Attention may now shift to whether other large private equity-owned UK retailers pursue public listings, or whether more strategic and family buyers step in for assets that private equity firms are looking to exit.

Sources

Sources accessed on October 07, 2026. Figures as reported by the sources above.

Frequently Asked Questions

Who is buying Boots and for how much?

Wittington Investments, the holding company of Canada's Weston family, is buying Boots for approximately US$8.9 billion, inclusive of assumed debt. Fairfax Financial Holdings is partnering on the deal and is expected to own 50 percent of Boots' equity after closing.

When is the Boots acquisition expected to close?

The transaction is subject to regulatory approval and customary closing conditions. The companies said on October 7, 2026, that they expect it to be completed in the first quarter of 2027.

What parts of Boots are included in the sale?

The sale includes Boots' UK and Irish retail operations, its opticians chain, the No7 beauty brand and a franchise arm in Thailand. Boots' businesses in Germany and Mexico are not included and will be retained by their current owner.

Who is selling Boots?

Boots is being sold by its private equity owners, Sycamore Partners. Stefano Pessina, Boots' long-term backer, is also exiting, though he will retain stakes in Farmacias Benavides in Mexico and Alliance Healthcare Deutschland.

What is Wittington Investments?

Wittington Investments is the private holding company for the Weston family based in Canada. It is the controlling shareholder of George Weston Limited and, through it, Loblaw Companies Limited and Choice Properties. Loblaw owns Shoppers Drug Mart, Canada's largest pharmacy, health and beauty business.

AI Notice: This article was created wholly or predominantly with the assistance of artificial intelligence and was published without human editorial review.

This article is for general information only and does not constitute investment advice. Always do your own research before making trading decisions.

About the author: This article was researched and written by the editorial team at Brokertable, which covers stock and equity trading for retail traders and investors. We focus on practical, fact-checked guidance and do not publish unverified claims.